Related Experiment Video
Updated: Jun 25, 2025

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
Juxtaglomerular apparatus-mediated homeostatic mechanisms: therapeutic implication for chronic kidney disease
Eiji Higashihara1, Takeo Harada2, Hiroshi Fukuhara1
1Department of Urology, Kyorin University School of Medicine, Mitaka, Japan.
The juxtaglomerular apparatus (JGA) mechanism influences how sodium-glucose cotransporter 2 inhibitors (SGLT2is) treat chronic kidney disease (CKD) and how tolvaptan affects autosomal dominant polycystic kidney disease (ADPKD). This understanding may improve kidney disease treatments.
Area of Science:
- Nephrology
- Pharmacology
- Physiology
Background:
- The juxtaglomerular apparatus (JGA) plays a crucial role in kidney homeostasis.
- The JGA's function is linked to tubuloglomerular feedback and the renin-angiotensin system.
- Sodium-glucose cotransporter 2 inhibitors (SGLT2is) and tolvaptan are key drugs in managing kidney diseases.
Purpose of the Study:
- To explore the JGA-mediated homeostatic mechanism.
- To assess the relationship between the JGA mechanism and the therapeutic effects of SGLT2is in chronic kidney disease (CKD).
- To evaluate the potential link between the JGA mechanism and tolvaptan's benefits in autosomal dominant polycystic kidney disease (ADPKD).
Main Methods:
- Review of clinical trials involving SGLT2is and tolvaptan.
- Analysis of the JGA-mediated homeostatic mechanism, including tubuloglomerular feedback.
- Examination of macula densa (MD) signaling in response to sodium load.
Main Results:
- Increased sodium load to the macula densa (MD) triggers adenosine production, constricting the afferent arteriole (Af-art) to protect glomeruli.
- MD signaling suppresses renin secretion and enhances sodium excretion, balancing filtration.
- In advanced CKD, increased MD adenosine production may relax the afferent arteriole (Af-art), maintaining sodium balance at the glomeruli's expense.
Conclusions:
- The JGA-mediated homeostatic mechanism is central to understanding SGLT2i efficacy in CKD.
- Tolvaptan's renal benefits in ADPKD may involve JGA-mediated mechanisms due to its action on sodium reabsorption.
- Further understanding of the JGA mechanism can guide the development of novel pharmacotherapies for kidney diseases.
Related Concept Videos
Hormonal Regulation
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Introduction to Urinary System
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

